Eidos Therapeutics Inc (NASDAQ:EIDX)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - EIDX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - EIDX

  • Market Cap$4.907bn
  • SymbolNASDAQ:EIDX
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS28249H1041

Company Profile

Eidos Therapeutics Inc is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. TTR is a protein that occurs naturally in the form of a tetramer and performs multiple beneficial roles, including the transport of essential hormones and vitamins. The company's product candidate, AG10, is an orally-administered small molecule designed to potently stabilize tetrameric TTR.Eidos Therapeutics Inc is a clinical development-stage biopharmaceutical company. It is focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR.

Latest EIDX news

Currently there for this company. Visit our news hub for other news .